- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$101.75 MnMarket Estimate, 2026
$108.97 MnMarket Forecast, 2034
$188.64 MnCAGR, 2026–2034
7.1%Executive Summary: Asia Pacific Atherectomy Devices Market
- Market Scope: Comprehensive Asia Pacific atherectomy devices market analysis covering device types, clinical applications, end-user categories, country-level breakdowns, and vascular intervention metrics.
- Market Valuation: Valued at USD 101.75 million (2025), estimated at USD 108.97 million (2026), and projected to reach USD 188.64 million by 2034, registering a CAGR of 7.10% (2026–2034).
- Primary Growth Drivers: Growing demand for minimally invasive surgical procedures, rising prevalence of peripheral artery diseases (PAD) linked to aging populations and lifestyle factors, expanding healthcare expenditures, and improved medical reimbursement policies. Restraints include high treatment costs, limited patient awareness, and stringent regulatory approval frameworks.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Type | Directional and rotational atherectomy devices (widely deployed for plaque excision in peripheral and coronary vessels) | Orbital and lateral atherectomy systems designed for calcified lesion modification |
| By Application | Peripheral and cardiovascular applications (account for the lion’s share due to rising PAD and cardiovascular disease rates) | Neurovascular applications expanding through advanced minimally invasive techniques |
| By End User | Hospitals and surgical centers (lead the market driven by advanced catheterization laboratory infrastructure) | Specialized outpatient surgical and cardiac centers |
| By Country | China (dominates the APAC region backed by robust economic development, rising healthcare spend, and high procedural volume) | India (projected to showcase a steady CAGR of 7.10% driven by changing lifestyles and aging demographics) and Japan (6.80% CAGR) |
Major Market Players & Market Structure
Market Structure: Highly competitive medical technology ecosystem featuring global cardiovascular device leaders competing intensely on catheter precision, plaque removal efficiency, clinical trial data, and regional distribution networks across Asia-Pacific.
Key Companies: Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.
Asia Pacific Atherectomy Devices Market Size
The Asia Pacific atherectomy devices market was valued at USD 101.75 million in 2025. The market is estimated at USD 108.97 million in 2026 and is projected to reach USD 188.64 million by 2034, growing at a CAGR of 7.10% from 2026 to 2034.
MARKET DRIVERS
Minimally Invasive Demand and PAD Cases Drive APAC Atherectomy Devices Market Growth
Growing demand for minimally invasive surgical procedures and increasing research and development activities in this region are primarily accelerating market growth. The rising amount spent on healthcare and the standard increase of peripheral artery diseases (PAD) is likely to fuel the Asia Pacific atherectomy devices market during the analysis period. Additionally, rising knowledge levels among patients regarding the diagnosis of peripheral coronary diseases and growing medical reimbursement policies for the vascular treatment processes are expected to lavish the growth rate of the market. Also, the clinical advantages provided and the continuous technological advancements in atherectomy devices are further estimated to support the market growth in this region.
MARKET RESTRAINTS
High Costs, Low Awareness, and Regulatory Hurdles Limit APAC Atherectomy Devices Market
Lack of awareness regarding the associated with among people and high costs associated with the treatment options using atherectomy devices are majorly impeding the market growth. Strict regulatory frameworks for the approval of the atherectomy devices and alternative therapies available in the market are expected to restrict the market growth in the Asia Pacific to some extent.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Type, Application, End-User, and Country. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC |
| Market Leaders Profiled | Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics. |
REGIONAL ANALYSIS
The Asia Pacific Atherectomy Devices Market will exhibit the highest growth rate in the forecast period because of the developing economy and increased healthcare costs.
The Chinese Atherectomy Devices Market dominates the Asia Pacific region and is expected to continue its dominance in the forthcoming years. The market size value of China is expected to be worth USD 54.3 Million by 2024 with a CAGR of 5.9% from 2026 to 2034 owing to the developing economy and growing healthcare expenditure in this region.
The Indian Atherectomy Devices Market is estimated to have a bright future during the forecast period and is predicted to showcase a CAGR value of 7.1% over the forecast period. Factors such as socioeconomic changes like smoking, unhealthy diet and consumption of liquor, and the aging population increase aimed diseases, which will demand market growth.
The Japanese Atherectomy Devices Market size value is expected to have a CAGR value of 6.8% during the forecast period.
KEY MARKET PLAYERS
Key market participants dominating the Asia Pacific Atherectomy Devices Market profiled in the report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.
MARKET SEGMENTATION
This research report on the Asia-Pacific Atherectomy Devices Market has been segmented and sub-segmented into the following categories:
By Type:
- Directional
- Rotational
- Orbital
- Lateral
By Application:
- Peripheral
- Cardiovascular
- Neurovascular
By End User:
- Hospitals
- Surgical Centers
- Research Laboratories
- Academic Institutes
By Country:
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of Asia Pacific